It seems we are edging closer to the roll-out of another coronavirus vaccine, as UK trials among 15,000 people - 27% of them over 65 - showed a jab made by US company Novavax to be 89.3% effective. The UK has secured 60 million doses which, if approved by the national medicines regulator, would be produced in Stockton-on-Tees with the aim of delivering them in the second half of the year. "These are enormously exciting findings," says Prof Paul Heath, who led the UK trials.
The Novavax jab is the first to show it is effective against the new variant of the virus discovered in the UK, the BBC's medical editor Fergus Walsh says. Trials in South Africa, where the most worrisome variant is most common, showed the vaccine to be 60% effective among those without HIV. Novavax's chief executive says this is "as good as we could have hoped", although Peter Openshaw, professor of experimental medicine at Imperial College London, described the lower level of protection as "a concern".

Offices could be more susceptible to coronavirus outbreaks than other types of workplaces, Public Health England figures suggest. The body recorded more than 60 suspected outbreaks in offices during the first two weeks of the current lockdown in England, with more than 500 suspected or confirmed in the second half of 2020. That's more than in supermarkets, construction sites, warehouses, restaurants and cafes combined. Read first-hand accounts from worried office workers in the report from 5 Live Investigates.

Buy now, pay later services are increasingly popular among online shoppers. But are they an easy target for fraudsters? Campaigners say so. Accountant Stephanie McDaid, 26, was baffled when a black dress turned up - with a £30 bill from deferred payment company Klarna - at her parents' house. A phone call confirmed she had been a victim of identity fraud. Stephanie was "really lucky", she says, the fraudsters had forgotten to change the delivery address. Klarna says rates of fraud are "extremely low" and its buyer protection policy means fraud victims are refunded. Read the full report.

Some front pages enjoy the prospect of 60 million more coronavirus vaccine doses being made available to Britons after UK trials showed positive results for the Novavax jab. It is, says the Daily Mail: "Another shot in the arm for Britain". The Sun declares the nation: "Union Vacc." The Guardian, however, suggests the EU could block millions of doses from being exported to the UK, amid continuing supply problems on the continent. Meanwhile, the Times quotes the prime minister saying he is confident the Oxford-AstraZeneca vaccine works for over-65s after Germany decided not to use it for that age group. Read the review.

If you're looking for entertainment, you might take inspiration from our interview with Ralph Fiennes and Carey Mulligan. The pair tell us why they chose to exhume the past in The Dig, a Netflix drama about the real-life discovery of an Anglo-Saxon burial ship at Sutton Hoo, Suffolk, in the 1930s. And, as it's Friday, why not test your knowledge of the past seven days' news in our quiz of the week?

From elsewhere